Abstract:Aim: To construct the bicistronic eukaryotic expression plasmid containing human bone morphogenetic protein-2 (BMP-2) and vascular endothelial growth factor 165 (VEGF-165)genes. Methods: This experiment was conducted at the Common Experimental Flatform of Tongji Medical College, Huazhong University of Science and Technology from March 2005 to October 2005. 1 Through polymerase chain reaction, target gene segment of pcDNA3.1-BMP2 and pUC-CAGGS-VEGF165 were subcloned and new estriction enzyme cutting sites were inducted, then were directionally connected to eukaryotic expression vector pIRES, bicistronic mRNA of two target gene was expressed when constructing. Recombinant plasmid was identified through polymerase chain reaction, enzyme analysis and DNA sequencing. 2 Recombinant plasmid transfected in vitro mouse bone marrow stroma cell induced by liposome. The expression of BMP-2 and VEGF-165 genes was detected through reverse transcriptase-polymerase chain reaction. Results: 1 Construction and id entification of bicistronic eukaryotic expression plasmid pIRES-BMP2-VEGF165: Recombinant plasmid pIRES-BM P2-VEGF165 was treated with Xho I/Mlu I and Xba I /Not I. Electropherosis of 1% agarose showed that there were 1.2 kbp human BMP-2 band and 592 bp vascular endothelial growth factor 165 band enzyme band and the electropherosis band of polymerase chain reaction were placed in the same position. Polymerase chain reaction, enzyme analysis and DNA sequencing proved that the inserting segment direction of target gene was right and no mutation appeared in DNA sequencing. 2 Expression of BMP-2 and VEGF-165 mRNA: transfected pIRES empty plasmid was as negative control, RNA of transfected cells was extracted 48 hours later, then were performed reverse transcriptase-polymerase chain reaction with P1, P2, P3, and P4 as primer. Results demonstrated that mouse bone marrow stroma cell with transfected pIRES-HMP2-VEGF165 amplified 1.2 kbp and 592 bp two bands, which proved that this recombinant plasmid could co-express in vitro bicistronic eukaryotic expression plasmid containing BMP-2 and VEGF-165 mRNA. Conclusion: Bicistronic eukaryotic expression plasmids containing BMP-2 and VEGF-165 mRNA are constructed successfully, which provide the foundation for combination gene therapy in bone defect.

Construction of Eukaryotic Bicistronic Expression Vector Pcdna3.1ab and Its Expression

Construction of a Eukaryotic Expression Vector Pegfp-C1-bmp-2

Construction and Identification of Eukaryotic Expression Vector for HCMV IE1-GFP Fusion Protein

Construction and Expression Efficiency of Bicistronic Expression Vector DV

[Construction and Expression of a Novel Bisbicistronic Expression Vector: Pcmv-Myc-ires-egfp].

Construction of recombinant vectors introducing ubiquitous expression or tissue-specific expression in Caenorhabditis elegans

Construction and Expression of Eukaryotic Expression Vector Plc3-Egfp

Construction of CCNL1 Eukaryotic Expression Vector and Identification of Expression of CCNL1 in MDA-MB-231 Cells

Construction of a eukaryotic expression vector expressing three exogenous genes

The Construction of Bacillus subtilis Integration Vectors and Genomic Reconstruction

Construction and Expression of the Wild-Type MLK3 Eukaryotic Expression Plasmid Vector

Construction and Identification of Eukaryotic Expression Vector Pcdna3.1 (+)-ABCG2

Construction and Identification of Co-Expressing Recombinant Baculovirus Vector with Dual Promoters

Construction of Eukaryotic Expression Plasmid Containing Human Polymorphic Epithelial Mucin and Granulocyte Macrophage Colony Stimulating Factor

The Construction of Intercellular Adhesion Molecule-1 Cdna Expression Vector

Construction and Expression of Eukaryotic Coexpression Plasmid Containing BCR/ABL Gene and SEA Gene

Construction of the Expression Vector with Double Report Gene of EGFP-LacZ and Its Expression in Vitro

[Construction of an Expression Vector with a Bicistron of Green Fluorescent Protein and HCV 5'NCR Controlled Luciferase Gene and Its Expression in Hepatocytes].

Construction and identification of eukaryotic expression plasmid MCP-1

Construction and in vitro expression of bicistronic eukaryotic expression plasmid containing human bone morphogenetic protein-2 and vascular endothelial growth factor 165 genes

Construction of a recombinant plasmid expressing HBV core antigen and A3C fusion protein